Vascular PTPs: Current developments and challenges for exploitation in Type 2 diabetes-associated vascular dysfunction

Biochemical and Biophysical Research Communications

Volumn 389, Issue 1, 2009, Pages 1-4

  Popov, Doina ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Endothelial cells; Growth factors signaling; Hyperglycemia; Insulin; Oxidation; Phosphatase inhibitors; Phosphorylation; Vascular smooth muscle cells

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR; PROTEIN TYROSINE PHOSPHATASE SHP;

ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHORT SURVEY; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD VESSELS; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; GLUCOSE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MYOCYTES, SMOOTH MUSCLE; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES; RATS;

EID: 70349121269     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.110     Document Type: Short Survey

References (40)

1. Hornberg J.J., Bruggeman F.J., Binder B., Geest C.R., de Vaate A.J., Lankelma J., Heinrich R., and Westerhoff H.V. Principles behind the multifarious control of signal transduction. ERK phosphorylation and kinase/phosphatase control. FEBS J. 272 (2005) 244-258
2. Junttila M.R., Li S.-P., and Westermarck J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J. 22 (2008) 954-965
3. Moorhead G.B., De Wever V., Templeton G., and Kerk D. Evolution of protein phosphatases in plants and animals. Biochem. J. 417 (2009) 401-409
4. McConnell J.L., and Wadzinski B.E. Targeting protein serine/threonine phosphatases for drug development. Mol. Pharmacol 75 (2009) 1249-1261
5. Kinney C.M., Chandrasekharan U.M., Yang L., Shen J., Kinter M., McDermott M.S., and DiCorleto P.E. Histone H3 as a novel substrate for MAP kinase phosphatase-1. Am. J. Physiol. Cell. Physiol. 296 (2009) C242-C249
6. Whetzel A.M., Bolick D.T., and Hedrick C.C. Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3. Am. J. Physiol. Cell. Physiol. 296 (2009) C339-C345
7. Kappert K., Peters K.G., Böhmer F.D., and Östman A. Tyrosine phosphatases in vessel wall signaling. Cardiovasc. Res. 65 (2005) 587-598
8. Tonks N.K. PTP1B: from the sidelines to the front lines!. FEBS Lett. 546 (2003) 140-148
9. Chen K., Kirber M.T., Xiao H., Yang Y., and Keaney Jr. J.F. Regulation of ROS signal transduction by NADPH oxidase 4 localization. J. Cell Biol. 181 (2008) 1129-1139
10. Harris D.L., and Joyce N.C. Protein tyrosine phosphatase, PTP1B, expression and activity in rat corneal endothelial cells. Mol. Vis. 13 (2007) 785-796
11. Hendriks W.J., Elson A., Harroch S., and Stoker A.W. Protein tyrosine phosphatases: functional inferences from mouse models and human diseases. FEBS J. 275 (2008) 816-830
12. Tonks N.K. Redox redux: revisiting PTPs and the control of cell signaling. Cell 121 (2005) 667-670
13. Tonks N.K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. 7 (2006) 833-846
14. Liang F., Kumar S., and Zhang Z.-Y. Proteomic approaches to studying protein tyrosine phosphatases. Mol. BioSyst. 3 (2007) 308-316
15. Abe J.-I., and Woo C.-H. NADPH oxidase in vascular injury: a new insight about its regulation and role in T cells. Circ. Res. 104 (2009) 147-149
16. Tabet F., Schiffrin E.L., Callera G.E., He Y., Yao G., Östman A., Kappert K., Tonks N.K., and Touyz R.M. Redox-sensitive signaling by Angiotensin II involves oxidative inactivation and blunted phosphorylation of Protein Tyrosine Phosphatase SHP-2 in vascular smooth muscle cells from SHR. Circ Res. 103 (2008) 149-158
17. Salmeen A., and Barford D. Methods for preparing crystals of reversibly oxidized proteins: crystallization of protein tyrosine phosphatase 1B as an example. Methods Mol. Biol. 476 (2009) 97-112
18. Wang L.D. S-nitrosylation of protein tyrosine phosphatase in endothelial cells under flow. FASEB J. 21 (2007) 638.9
19. Deem T.L., Abdala-Valencia H., and Cook-Mills J.M. VCAM-1 activation of endothelial cell protein tyrosine phosphatase 1B. J. Immunol. 178 (2007) 3865-3873
20. Chen S.C., Khanna R.S., Bessette D.C., Samayawardhena L.A., and Pallen C.J. Protein tyrosine phosphatase alpha (PTPα) complexes with the IGF-1 receptor and undergoes IGF-1-stimulated tyrosine phosphorylation that mediates cell migration. Am. J. Physiol. Cell. Physiol. 297 (2009) C133-C139
21. Kiyan J., Haller H., and Dumler I. The tyrosine phosphatase SHP-2 controls urokinase - dependent signaling and functions in human vascular smooth muscle cells. Exp. Cell. Res. 315 (2009) 1029-1039
22. Kappert K., Paulsson J., Sparwel J., Leppanen O., Hellberg C., Östman A., and Micke P. Dynamic changes in the expression of DEP-1 and other PDGF receptor-antagonizing PTPs during onset and termination of neointima formation. FASEB J. 21 (2007) 523-534
23. Radhakrishnan Y., Maile L.A., Ling Y., Graves L.M., and Clemmons D.R. Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-2 kinase activation via Grb2-associated p85 in vascular smooth muscle cells. J. Biol. Chem. 283 (2008) 16320-16331
24. Shen X., Xi G., Radhakrishnan Y., and Clemmons D.R. Identification of novel SHPS-1-associated proteins and their roles in regulation of 2 insulin-like growth factor-dependent responses in vascular smooth muscle cells. Mol. Cell. Proteomics 8 (2009) 1539-1551
25. Pandey N.R., Benkirane K., Amiri F., and Schiffrin E.L. Effects of PPAR-gamma knock-down and hyperglycemia on insulin signaling in vascular smooth muscle cells from hypertensive rats. J. Cardiovasc. Pharmacol. 49 (2007) 346-354
26. Rajala R.V.S., Wiskur B., Tanito M., Callegan M., and Rajala A. Diabetes reduces autophosphorylation of retinal insulin receptor and increases Protein-Tyrosine Phosphatase-1B activity. Invest. Ophthalmol. Vis. Sci. 50 (2009) 1033-1040
27. ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose. Cardiovasc. Res. 82 (2009) 421-429
28. 2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc. Natl. Acad. Sci. USA 105 (2008) 7147-7152
29. Kim J.-A., Wei Y., and Sowers J.R. Role of mitochondrial dysfunction in insulin resistance. Circ. Res. 102 (2008) 401-414
30. Potenza M.A., Addabbo F., and Montagnani M. Vascular actions of insulin with implications for endothelial dysfunction. Am. J. Physiol. Endocrinol. Metab. 297 (2009) E568-E577
31. Zhuang D., Pu Q., Ceacareanu B., Chang Y., Dixit M., and Hassid A. Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B. Am. J. Physiol. Heart Circ. Physiol. 295 (2008) H163-H173
32. Nakamura Y., Patrushev N., Inomata H., Mehta D., Kim H.W., Urao N., Razvi M., Kini V., Mahadev K., Goldstein B.J., Mckinney R., Fukai T., and Ushio-Fukai M. Role of Protein Tyrosine Phosphatase 1B in VEGF signaling and cell-cell adhesions in endothelial cells. Circ. Res. 102 (2008) 1182-1191
33. Erbe D.V., Klaman L.D., Wilson D.P., Wan Z.-K., Kirincich S.J., Will S., Xu X., Kung L., Wang S., Tam S., Lee J., and Tobin J.F. Prodrug delivery of novel PTP1B inhibitors to enhance insulin signaling. Diabetes Obes. Metab. 11 (2009) 579-588
34. Bhattarai B.R., Shrestha S., Ham S.W., Kim K.R., Cheon H.G., Lee K.H., and Cho H. 2-O-carboxymethylpyrogallol derivatives as PTP1B inhibitors with antihyperglycemic activity. Bioorg. Med. Chem. Lett. 17 (2007) 5357-5360
35. Heneberg P. Use of protein tyrosine phosphatase inhibitors as promising targeted therapeutic drugs. Curr. Med. Chem. 16 (2009) 706-733
36. Bloomgarden Z.T. Diabetes treatment. Diabetes Care 32 (2009) e25-e30
37. Ottana R., Maccari R., Ciurleo R., Paoli P., Jacomelli M., Manao G., Camici G., Laggner C., and Langer T. 5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors. Bioorg. Med. Chem. 17 (2009) 1928-1937
38. Barr A.J., Ugochukwu E., Lee W.H., King O.N., Filippakopoulos P., Alfano I., Savitsky P., Burgess-Brown N.A., Muller S., and Knapp S. Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell 136 (2009) 352-363
39. McConnell J.L., and Wadzinski B.E. Targeting protein serine/threonine phosphatases for drug development. Mol. Pharmacol. 75 (2009) 1249-1261
40. Forghieri M., Laggner C., Paoli P., Langer T., Manao G., Camici G., Bondioli L., Prati F., and Costantino L. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors. Bioorg. Med. Chem. 17 (2009) 2658-2672